CODX AMERICA2030 SC13G 02/19/19

Company

Co-Diagnostics, Inc.

Filed

May 9, 2019

Accession Number

0001469709-19-000073

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →